Collaborative Network to Take Responsibility for Oral Anticancer Therapy (CONTACT)
CONTACT: A Prospective Interventional Multicentre Before-after Study for the Implementation of a Care Pathway to Increase Self-management of Patients With Cancer Who Are Treated With Oral Anticancer Medications
This study aims to develop, implement and evaluate a care pathway for patients with cancer who are treated with oral anticancer drugs (OACD).
The care pathway will be developed in six hospitals in Flanders, and will be adapted to the local setting and situation.
The investigators hypothesize that the implementation of a care pathway will increase the quality of the drug therapy, the communication between health care professionals (HCPs) and patients, and will lead to an improved level of self-management and adherence. Moreover, the invesitgators hypothesize that the care pathway will facilitate the communication between HCPs in the hospital setting and in ambulatory care, and will improve counseling skills, self-efficacy and self-confidence of HCPs.
At the end of the study, a roadmap for the nation-wide implementation of a similar care pathway will be constructed based on the experiences of the participating hospitals. This roadmap will certainly include an e-learning platform for healthcare professionals.
調査の概要
詳細な説明
For each hospital, an individual care pathway will be developed following the 7-phase model by Vanhaecht et al., 2011. This methodology aims to offer a systematic approach in 7 phases for the support of an interdisciplinary team in the development of new care pathways or in the improvement of existing ones.
The before-part of the study includes phases 1 to 4 that aim to map current practice in detail and to translate these findings into the development of a care pathway. Current practice will be investigated using mixed methods comprising:
- surveys evaluating care on the level of the hospital
- semi-structured interviews with healthcare professionals (HCP) and patients
- outcome assessments in patients included in the study (self-management, adherence, satisfaction with care, satisfaction with information, quality of life) using validated questionnaires at the start of the therapy, after 1 month and after three months
- outcome assessments in healthcare professionals at baseline (self-efficacy and perceptions on self-management) using validated questionnaires
- training and feedback sessions on counseling for HCPs
Based upon these findings, a care pathway in each hospital will be developed by a local project team of different stakeholders from different disciplines.
The after-part of the study includes phase 5-7 in which the care pathway is implemented, evaluated and continuously followed up.
Implementation and evaluation take place at the same time. The evaluation includes:
- outcome assessments in patients (newly recruited) at the start of the therapy, after 1 month and after three months
- outcome assessments in HCPs (follow up)
- evaluation of counseling skills
- focus group discussions and interviews with HCPs to evaluate the development and implementation of the care pathway.
At the end of the study a comparison of outcomes before and after the implementation will be made to study the impact of the care pathway on the before mentioned aspects (see "Brief Summary").
研究の種類
入学 (予想される)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Antwerpen
-
Turnhout、Antwerpen、ベルギー、2300
- 募集
- Az Turnhout
-
コンタクト:
- Lise-Marie Kinnaer, PharmD
- 電話番号:32 16328265
- メール:lisemarie.kinnaer@kuleuven.be
-
-
Oost-Vlaanderen
-
Ghent、Oost-Vlaanderen、ベルギー、9000
- 募集
- Maria Middelares Gent
-
コンタクト:
- Lise-Marie Kinnaer, PharmD
- 電話番号:32 16328265
- メール:lisemarie.kinnaer@kuleuven.be
-
-
Vlaams-Brabant
-
Bonheiden、Vlaams-Brabant、ベルギー、2820
- 募集
- Imelda Bonheiden
-
コンタクト:
- Lise-Marie Kinnaer, PharmD
- 電話番号:32 16328265
- メール:lisemarie.kinnaer@kuleuven.be
-
-
West-Vlaanderen
-
Kortrijk、West-Vlaanderen、ベルギー、8000
- 募集
- AZ Groeninge Kortrijk
-
コンタクト:
- Veerle Foulon, Prof. Dr.
- メール:veerle.foulon@kuleuven.be
-
コンタクト:
- Lise-Marie Kinnaer, PharmD
- 電話番号:32 016328265
- メール:lisemarie.kinnaer@kuleuven.be
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- a hematological cancer of solid tumor
- starting an oral anticancer drug for the first time
- able to understand and speak Dutch
Exclusion Criteria:
- patients following an adjuvant oral anticancer therapy (e.g. tamoxifen)
- patients following a therapy with a study drug
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:支持療法
- 割り当て:非ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
---|---|
介入なし:Non-care pathway
This arm comprises patients before the implementation of the care pathway. Patients starting with an oral anticancer therapy participate in the current care process. Outcomes are assessed at start of treatment, after 1 and after 3 months. The decision to start with an oral anticancer therapy depends solely on the treating physician. |
|
実験的:Care Pathway
This arm comprises patients after the implementation of the care pathway. Patients starting with an oral anticancer therapy in this arm, receive care as is described by the novel designed care pathway. Outcomes are again assessed at start of treatment, after 1 and after 3 months. The decision to start with an oral anticancer therapy depends solely on the treating physician. |
The care pathway will consist of procedures of care in the hospital (e.g.
consultations with doctors, contact moments with nurses, ...) that describe the initiation of an oral anticancer therapy and the further follow up.
The care pathway should describe how care can efficiently be organised.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Change in self-management skills
時間枠:at the start of the therapy, after one and three months
|
There is no gold standard to define self-management. A definition from Barlow et al., 2002 (2) defines self-management as follows: the ability of an individual to manage the symptoms, treatment, physical and psychosocial consequences and life style changes due to his/her condition. Adequate self-management refers to the ability to monitor one's condition and to effect cognitive, behavioural and emotional responses necessary to maintain a satisfactory quality of life. The studied self-management skills in this project comprise "social integration and support", "health service navigation", "constructive attitudes and approaches", "skill and technique acquisition" and "emotional distress". |
at the start of the therapy, after one and three months
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Change in medication Adherence
時間枠:after one and three months of therapy
|
after one and three months of therapy
|
|
Change in patient satisfaction with treatment using the Cancer Therapy Satisfaction Questionnaire (CTSQ)
時間枠:after one and three months
|
after one and three months
|
|
Change in patient satisfaction with care using Out-patsat 35
時間枠:at the start of the therapy, after one and three months
|
The outpatsat is a questionnaire for ambulatory cancer patients in which they are asked to rate in different subscales their perceptions on care delivered by doctors, nurses and rate te overall organisation (accessibility of the hospital, ease of reaching the hospital by telephone, ...) during their stay at day hospital of consultations
|
at the start of the therapy, after one and three months
|
Health Related Quality of Life
時間枠:at the start of the therapy, after one and three months
|
at the start of the therapy, after one and three months
|
|
Change in Distress using the Distress Barometer
時間枠:at the start of the therapy, after one and three months
|
at the start of the therapy, after one and three months
|
|
Efficacy of treatment Using ECOG performance scale and RECIST criteria
時間枠:at the start of the therapy, after one and three months
|
at the start of the therapy, after one and three months
|
|
Toxicity of treatment
時間枠:at the start of the therapy, after one and three months
|
Summarizing adverse drug events
|
at the start of the therapy, after one and three months
|
Cost of care
時間枠:at the start of the therapy, after one and three months
|
Prospective report on health care expenditures (use of healthcare and other services, use of medicines, …)
|
at the start of the therapy, after one and three months
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Change in Self-efficacy in HCPs using the Self-efficacy and Performance in Self-management Instrument (SEPSS)
時間枠:at baseline (before the implementation of the care pathway) and after 24 months (during implementation)
|
SEPSS investigates the ability of a HCP to evaluate their own performance in daily practice and caregiving.
|
at baseline (before the implementation of the care pathway) and after 24 months (during implementation)
|
Change in perceptions on self-management in HCPs using the Clinician Support for Patient activation measure
時間枠:at baseline (before the implementation of the care pathway) and after 24 months (during implementation)
|
at baseline (before the implementation of the care pathway) and after 24 months (during implementation)
|
協力者と研究者
スポンサー
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始
一次修了 (予想される)
研究の完了 (予想される)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
Implementation of a care pathwayの臨床試験
-
Compedica IncProfessional Education and Research Institute募集
-
Johns Hopkins UniversityJuvenile Diabetes Research Foundation; National Eye Institute (NEI)募集
-
Johns Hopkins UniversityNational Eye Institute (NEI)完了
-
DeRoyal Industries, Inc.Lincoln Memorial University完了皮膚感作 | 機械的、熱的、および放射線刺激に対する皮膚反応アメリカ
-
University of Stellenbosch完了
-
Copenhagen University Hospital at HerlevRigshospitalet, Denmarkわからない